Santhera Pharmaceuticals Holding AG
F:S3F
Wall Street
Price Targets
S3F Price Targets Summary
Santhera Pharmaceuticals Holding AG
According to Wall Street analysts, the average 1-year price target for S3F is 26.86 EUR with a low forecast of 26.6 EUR and a high forecast of 27.65 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is S3F's stock price target?
Price Target
26.86
EUR
According to Wall Street analysts, the average 1-year price target for S3F is 26.86 EUR with a low forecast of 26.6 EUR and a high forecast of 27.65 EUR.
What is Santhera Pharmaceuticals Holding AG's Revenue forecast?
Projected CAGR
60%
For the last 13 years the compound annual growth rate for Santhera Pharmaceuticals Holding AG's revenue is 21%. The projected CAGR for the next 3 years is 60%.